m+Medelevator.RU
← Поиск публикаций
Frontiers in chemistry · 2026

Transition-metal-catalyzed C-S bond formation: recent developments and pharmaceutical applications.

СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Muneer Saima, da Silva Brito Nathalia, Kanwal Aqsa, Tariq Ayesha, Rasool Nasir, Brito João Modesto, Santos Rafaely B C, Imran Muhammad, Saba Sumbal, Rafique Jamal

Аннотация

Due to widespread applications of sulfur-containing frameworks, the construction of the C-S bond has emerged as a useful tool for synthetic organic and medicinal chemists in recent years. Transition-metal-catalyzed carbon-sulfur (C-S) bond formation represents a cornerstone of advanced organic synthesis due to its pivotal role in pharmaceuticals, agrochemicals, and functional materials. This review provides a comprehensive and structured overview of recent developments in C-S bond formation, covering both classical late transition metals (Pd, Ni, and Cu) and a broad range of miscellaneous metals (Mo, Ir, Rh, Cr, Mn, Zn, and Sc). Palladium catalysis, typically supported by phosphine or N-heterocyclic carbene ligands, enables efficient thiolation of aryl halides using thiols, disulfides, or sulfur surrogates. Nickel catalysis as a cost-effective alternative to Pd, displaying complementary reactivity toward aryl, alkyl, and heteroaryl electrophiles, often under ligand-controlled or reductive conditions, while copper follows Ullmann-type C-S couplings and oxidative thiolations using thiols, sulfinates, or elemental sulfur. Beyond these, molybdenum catalysts promote dehydrative and borrowing-hydrogen thio-etherification of alcohols, whereas iridium-based photoredox catalysis converts sodium aryl sulfinates into thioesters and thioalkynes. This review highlights the high compatibility of these methodologies with drug-like molecules and the significance of these methodologies.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты